We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
+9.16%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.39B
AUM Growth
-$42.4M
(-1.7%)
Cap. Flow
-$177M
Cap. Flow
% of AUM
-7.4%
Top 10 Holdings %
Top 10 Hldgs %
16.2%
Holding
256
New
23
Increased
45
Reduced
142
Closed
31
Top Buys
| 1 |
TWNK
Hostess Brands, Inc. Class A Common Stock
TWNK
|
+$25.7M |
| 2 |
Supernus Pharmaceuticals
SUPN
|
+$17.7M |
| 3 |
RXDX
Ignyta, Inc.
RXDX
|
+$13.3M |
| 4 |
PDCE
PDC Energy, Inc.
PDCE
|
+$13.2M |
| 5 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
+$12.4M |
Top Sells
| 1 |
Veeva Systems
VEEV
|
+$45M |
| 2 |
Take-Two Interactive
TTWO
|
+$19.4M |
| 3 |
MSCC
Microsemi Corp
MSCC
|
+$18.7M |
| 4 |
Exelixis
EXEL
|
+$15.4M |
| 5 |
Generac Holdings
GNRC
|
+$14.9M |
Sector Composition
| 1 | Technology | 20.31% |
| 2 | Industrials | 18.87% |
| 3 | Healthcare | 15.79% |
| 4 | Consumer Discretionary | 11.97% |
| 5 | Financials | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Supernus Pharmaceuticals
SUPN
$2.79B
| $21.5M | 0.9% |
+498,230
| New | +$17.7M |
|
52
Primoris Services
PRIM
$4.66B
| $20.9M | 0.87% |
838,934
-37,800
| -4% | -$893K |
|
|
BLUE
53
DELISTED
bluebird bio
BLUE
| $20.6M | 0.86% |
15,145
+10,212
| +207% | +$12.3M |
|
54
Guidewire Software
GWRE
$12.5B
| $20.4M | 0.85% |
296,260
-15,202
| -5% | -$967K |
|
55
Alarm.com
ALRM
$2.63B
| $19.9M | 0.83% |
527,782
-8,550
| -2% | -$286K |
|
56
Teladoc Health
TDOC
$1.7B
| $19.6M | 0.82% |
565,957
+38,000
| +7% | +$1.11M |
|
57
Moelis & Co
MC
$5.02B
| $17.9M | 0.75% |
460,001
-7,910
| -2% | -$295K |
|
58
Customers Bancorp
CUBI
$2.65B
| $17.8M | 0.74% |
629,146
-24,998
| -4% | -$739K |
|
|
OCLR
59
DELISTED
Oclaro Inc.
OCLR
| $17.4M | 0.73% |
1,858,334
+526,448
| +40% | +$4.77M |
|
60
Tennant Co
TNC
$1.47B
| $17.1M | 0.72% |
232,308
-11,761
| -5% | -$852K |
|
61
Burlington
BURL
$21.7B
| $17.1M | 0.72% |
186,322
-57,770
| -24% | -$5.56M |
|
62
Planet Fitness
PLNT
$4.14B
| $17.1M | 0.71% |
732,815
-34,440
| -4% | -$722K |
|
|
RXDX
63
DELISTED
Ignyta, Inc.
RXDX
| $16.9M | 0.71% |
+1,633,345
| New | +$13.3M |
|
64
Innospec
IOSP
$2.08B
| $16.9M | 0.7% |
257,253
+10,317
| +4% | +$663K |
|
65
Matthews International
MATW
$857M
| $16.7M | 0.7% |
272,369
-39,280
| -13% | -$2.57M |
|
|
SLCA
66
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $16.3M | 0.68% |
459,437
+194,044
| +73% | +$7.64M |
|
67
Jack in the Box
JACK
$286M
| $16.3M | 0.68% |
165,409
-62,991
| -28% | -$6.5M |
|
68
Steven Madden
SHOO
$3.17B
| $15.9M | 0.66% |
595,316
-28,197
| -5% | -$716K |
|
69
Meritage Homes
MTH
$4.95B
| $15.1M | 0.63% |
717,876
-33,450
| -4% | -$664K |
|
|
OPB
70
DELISTED
Opus Bank Common Stock
OPB
| $14.8M | 0.62% |
609,732
+9,172
| +2% | +$202K |
|
|
CPE
71
DELISTED
Callon Petroleum Company
CPE
| $14.7M | 0.62% |
138,998
-6,516
| -4% | -$764K |
|
|
SAGE
72
DELISTED
Sage Therapeutics
SAGE
| $14.6M | 0.61% |
182,804
+37,786
| +26% | +$2.73M |
|
|
ALDR
73
DELISTED
Alder Biopharmaceuticals
ALDR
| $13.7M | 0.57% |
1,193,672
+591,840
| +98% | +$10.9M |
|
|
NEX
74
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $13.5M | 0.56% |
844,227
+4,199
| +0.5% | +$61.9K |
|
75
AtriCure
ATRC
$1.77B
| $13.3M | 0.55% |
546,761
-29,756
| -5% | -$633K |
|
Similar funds
AWE
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
Emerald Advisers's Q2 2017 Portfolio in Review
As of Q2 2017, Emerald Advisers held 256 positions worth $2.39B, down 1.7% from $2.44B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Emerald Advisers withdrew a net $177M in Q2 2017, closing 31 positions and reducing 142 holdings. Its most notable exit was Exelixis, an estimated $15.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Emerald Advisers opened a new position in Hostess Brands, Inc. Class A Common Stock worth $25.6M.
- Emerald Advisers's largest Q2 2017 buy was Hostess Brands, Inc. Class A Common Stock: 1,591,603 shares worth $25.6M.
- Emerald Advisers added most to bluebird bio in Q2 2017, an estimated $12.3M increase.
- Emerald Advisers's biggest Q2 2017 reduction was Veeva Systems, cutting an estimated $45M.
- Emerald Advisers fully exited Exelixis in Q2 2017, selling an estimated $15.4M.
- Emerald Advisers's ten largest holdings make up 16% of its $2.39B portfolio in Q2 2017.
- Emerald Advisers opened 23 new positions and closed 31 in Q2 2017.
- Emerald Advisers's portfolio value fell 1.7% quarter-over-quarter to $2.39B.
Based on Emerald Advisers's 13F filing for Q2 2017, filed 28 Jul 2017.